Authors: WELLES L SAVILLE MW LIETZAU J PLUDA JM WYVILL KM FEUERSTEIN I FIGG WD LUSH R ODOM J WILSON WH FAJARDO MT HUMPHREY RW FEIGAL E TUCK D STEINBERG SM BRODER S YARCHOAN R

Citation: L. Welles et al., PHASE-II TRIAL WITH DOSE TITRATION OF PACLITAXEL FOR THE THERAPY OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED KAPOSIS-SARCOMA, Journal of clinical oncology, 16(3), 1998, pp. 1112-1121

Authors: PLUDA JM WYVILL KK LIETZAU J FIGG WD WHITCUP SM FEIGAL E HUMPHREY R WELLES L YARCHOAN R

Citation: Jm. Pluda et al., A PHASE-I TRIAL ADMINISTERING THE ANGIOGENESIS INHIBITOR TNP-470 (AGM-1470) TO PATIENTS (PTS) WITH HIV-ASSOCIATED KAPOSIS-SARCOMA (KS), Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 13-13

Authors: WELLES L LITTLE R WYVILL K PLUDA J FIGG W LIETZAU J MERCED T HUMPHREY R YARCHOAN R

Citation: L. Welles et al., PRELIMINARY-RESULTS OF A PHASE-II STUDY OF ORAL THALIDOMIDE IN PATIENTS WITH HIV-INFECTION AND KAPOSIS-SARCOMA (KS), Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 20-20

Authors: WELLES L DORFMAN H VALENTINE ES WIERNIK PH

Citation: L. Welles et al., LOW-GRADE MALIGNANT HEMANGIOENDOTHELIOMA OF BONE - A DISEASE POTENTIALLY CURABLE WITH RADIOTHERAPY, Medical and pediatric oncology, 23(2), 1994, pp. 144-148